<?xml version="1.0" encoding="UTF-8"?>
<p>The bio-silver nanoparticles (12.5 ppm) were efficient against the Gram-positive pathogen 
 <italic>Bacillus subtilis</italic> ATCC 6633 and the Gram-negative pathogens 
 <italic>Pseudomonas aeruginosa</italic> ATCC 9022, 
 <italic>Escherichia coli</italic> ATCC 8739 with zones of inhibition (ZOIs) of 11 ± 0.89, 12.66 ± 0.52, and 10.33 ± 0.51 mm, respectively (
 <xref ref-type="fig" rid="antibiotics-09-00641-f005">Figure 5</xref>). Doubling the Ag-NPs concentration (25 ppm) conferred better efficiency, and the ZOIs increased to 14 ± 0.9, 15.5 ± 0.5, and 12 ± 0.9 mm for the pathogens 
 <italic>B. subtilis</italic>, 
 <italic>P. aeruginosa</italic>, and 
 <italic>E. coli</italic>, respectively. Moreover, the Gram-positive pathogen 
 <italic>Staphylococcus aureus</italic> ATCC 6538 and the Gram-negative pathogen 
 <italic>Salmonella typhimurium</italic> ATCC 14028 manifested a positive response for silver nanoparticles at 25 ppm, with recorded ZOIs of 10 ± 0.9 and 10 ± 0.47 mm, respectively. The biocolloidal silver (50 ppm) demonstrated a pronounced activity against all pathogens, recording ZOIs of 11.6 ± 0.5, 18.3 ± 0.5, 13.6 ± 1, 18 ± 0.9, and 12.3 ± 1 mm corresponding to 
 <italic>S. aureus</italic>, 
 <italic>B. subtilis</italic>, 
 <italic>P. aeruginosa</italic>, 
 <italic>E. coli</italic>, and 
 <italic>S. typhimurium</italic> respectively.
</p>
